Biomedical Sciences

Biomedical Sciences Experts

Jim Burns

President and CEO
CRISPR-Cas9 therapeutics
Casebia Therapeutics
United States of America


Jim Burns is President and CEO at Casebia. Burns has nearly 30 years of R&D experience in the biopharmaceutical industry and a proven track record of leading organizations that have successfully delivered therapeutics to patients across multiple therapeutic modalities. Prior to joining Casebia, Burns spent more than 25 years at Sanofi-Genzyme. First joining Genzyme in 1986, he advanced in multiple leadership roles to become Head of Sanofi’s North American R&D Hub, where he was responsible for coordinating R&D operations across key therapeutic areas. Burns earned his Bachelor of Science in Biology from Purdue University, and Doctorate in Bioengineering from the University of Illinois-Chicago, where his thesis work focused on drug delivery. Following his graduate studies, Burns was a post-doctoral researcher at the University of Florida. He was elected to the National Academies’ National Academy of Engineering in 2010. 

Research Interest

CRISPR Therapeutics, gene editing therapeutics, inherited diseases 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences